AzTrials
AzTrials

Pulmonary Disease, Chronic ObstructiveNCT02740673

Testing Cognitive Functions in Patients With COPD Using a Driving Simulator

A study testing Driving simulator in people with Pulmonary Disease, Chronic Obstructive, run by Aarhus University Hospital at 1 site in Denmark.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

Little is known about the causes and degree of cognitive dysfunction in patients with Chronic Obstructive Pulmonary Disease (COPD), especially their driving abilities. The purpose of the study is to examine the cognitive skills of patients with COPD by using a driving simulator and to examine correlations to factors… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pulmonary Disease, Chronic Obstructive
What is being tested?
Driving simulator
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteDenmark
Study dates
Jan 2019to Jan 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • a diagnosis of COPD (Forced Expiratory Volume in 1 second (FEV1) / Forced Vital Capacity (FVC) < 0,70)
  • no exacerbations within the last 6 weeks
  • valid driver's license and having driven a car within the last 3 months

Who cannot join

  • lacking the ability to use the driving simulator
  • no valid driver's license
  • alcohol abuse (> 21 units per week)
  • a known diagnosis of obstructive sleep apnea
  • uncorrected impaired vision or hearing
  • unstable ischemic heart disease, left-sided heart failure, severe neurologic diseases, cancer, severe peripheral vascular disease, severe psychiatric diseases, former apoplexia and uncontrolled hypertension, thyroid diseases or diabetes

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Aarhus University Hospital

    Aarhus, 8000

Other trials in Denmark

About this study

Little is known about the causes and degree of cognitive dysfunction in patients with Chronic Obstructive Pulmonary Disease (COPD), especially their driving abilities. The purpose of the study is to examine the cognitive skills of patients with COPD by using a driving simulator and to examine correlations to factors that may predict cognitive dysfunction in these patients.

Being tested
Driving simulator
Medical subject headings
Pulmonary Disease, Chronic Obstructive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Driving simulatorDevice

    Patients are asked to use a driving simulator to test their driving skills

Study groups in NCT02740673
Study groupRoleWhat they receive
Driving simulatorOtherUsing the driving simulator for 30 min.
Receives: Device: Driving simulator

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Standard deviation from the centre of the road

    Measuring how far from the centre of the road the patient has been driving in the driving simulation

    Measured: During the 30 min. of driving in the simulator

  2. Number of nil responses

    Measuring the number of times the patients doesn't react to the number "2" on the screen

    Measured: During the 30 min. of driving in the simulator

  3. Response time

    Measuring the mean amount of response time from the number "2" appears on the screen until the patient reacts

    Measured: During the 30 min. of driving in the simulator

  4. Number of off-road events per hour

    The number of times the car is off-road during the driving simulation

    Measured: During the 30 min. of driving in the simulator

Secondary outcomes (4)
  1. Number of patients with comorbidities

    Patients with comorbidities will be registered

    Measured: At enrolment

  2. Lung function tests

    Measured: At enrolment

  3. Depression and anxiety

    Using the Hospital Anxiety and Depression Scale

    Measured: At enrolment

  4. Cognitive functions

    Using the Mini Mental State Examination and the Clock Drawing Test

    Measured: At enrolment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2016 (estimated)
  2. Study startJan 2019 (estimated)
  3. Primary completionJan 2022 (estimated)
  4. Study completionJan 2022 (estimated)

Why it stopped: Technical issues

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02740673
Sponsor's protocol ID
Driving simulator, COPD, v.2
Status last verified
May 2018
First submitted
28 Dec 2015
Last updated
2 May 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Driving simulator in people with Pulmonary Disease, Chronic Obstructive, run by Aarhus University Hospital at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 2 May 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Standard deviation from the centre of the road (time frame: During the 30 min. of driving in the simulator). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 May 2019; AzTrials last refreshed its copy on 4 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in